Moreover, BridgeBio operates in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of BridgeBio's management as of the date of this release and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, we assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. BridgeBio Contact: Grace Rauh BridgeBio Pharma, Inc. Grace.rauh@bridgebio.com (917) 232-5478 Patient Advocacy Contact: Jocelyn Ashford BridgeBio Pharma, Inc. jocelyn.ashford@bridgebio.com (650) 452-4199 Source: BridgeBio Pharma, Inc.